Table 4.
Study | Population/diagnosis | M/F | Age (yrs) | Statistics | LV | RV | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EDV (%) | ESV (%) | SV (%) | EF (%) | Mass (%) | EDV (%) | ESV (%) | SV (%) | EF (%) | Mass (%) | |||||
This study |
n = 35 CHD |
26/9 |
22 ± 13 (7–62) |
CoV n = 35 |
4.3 | 10.2 | 5.1 | 3.9 | 6.0 | 4.0 | 7.7 | 5.5 | 5.5 | 6.2 |
Catalano [3] |
n = 45 Acquired/Healthy |
33/12 |
49 ± 20 (8–83) |
CoV n = 45 |
8 | 11 | 12 | 13 | ||||||
Clay [4] |
n = 20 Acquired/Healthy |
14/6 | 30 |
CoV n = 20 |
3.3 | 6.8 | 4.6 | 3.7 | ||||||
Hudsmith [6] |
n = 108 Healthy |
63/45 |
38 ± 12 (21–68) |
CoV* n = 12 |
2.7 | 3.3 | 5.2 | 9.6 | 10.7 | |||||
Karamitsos [7] |
n = 10 Healthy |
5/5 | 34 ± 14 |
CoV n = 10 |
2.6 | 6.9 | 3.4 | 2.9 | 5.8 | |||||
Maceira [8] |
n = 120 Healthy |
60/60 | (20–80) |
CoV n = 10 |
6.3 | 8.6 | 7.0 | 4.4 | 7.8 | |||||
Mooij [13] |
n = 60 ASD/TOF/Healthy |
34/26 | 21 ± 13 |
CoV* n = 60 |
3.6 | 10.5 | 6.6 | 5.8 | 5.3 | 6.4 | 13.0 | 11.8 | 8.0 | 11.3 |
Plein [10] |
n = 41 Acquired/Healthy |
23/18 |
53 (32–77) |
CoV n = 41 |
4.3 | 9.4 | 9.5 | 6.0 | 6.0 | |||||
Robbers-Visser [11] |
n = 60 Healthy |
30/30 | (8–17) |
CoV n = 15 |
5.3 | 13.9 | 3.3 | 2.3 | 6.1 | 3.4 | 7.6 | 4.5 | 2.0 | 8.9 |
Winter [15] |
n = 29 Systemic RV |
20/9 | 35 ± 12 |
CoV n = 20 |
10.0 | 12.7 | 12.2 | 7.5 |
Reported data are expressed as mean ± SD (range). * CoV, indexed for BSA
ASD atrial septal defect, TOF tetralogy of Fallot. Other abbreviations as in Table 3